53 results
Page 2 of 3
S-4
EX-10.9
nczj8e2u
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-10.4
ueyle8dz
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
EX-10.1
fkbt24
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
EX-10.3
7j8xybi
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
EX-10.5
n4rhzii s5whp34
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
EX-10.2
mhfkzm7me 3f8d63dzt
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-10.4
dx3idijlggbihmp5
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-10.1
fpo6pm8nwf0u6w
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-10.5
967abcxok mvdk2t
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-10.3
ptusrcomnr bmli
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-10.2
01r8vnfj
15 Dec 20
Additional proxy soliciting materials
3:32pm
6-K
EX-10.1
8i1a 1d7jxo
23 Sep 19
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
5:29pm
F-1/A
EX-10.1
jgwpu
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
EX-10.3
93oy y7cthuxb3e
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-10.4
op3eo fiq6
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.2
5iqkxay5vljt
7 Jan 19
Registration statement (foreign)
5:11pm
F-1
EX-10.10
j32w7m4kj3nsnfeuvt
7 Jan 19
Registration statement (foreign)
5:11pm
F-1
EX-10.5
vq7twgldzz16qgb
7 Jan 19
Registration statement (foreign)
5:11pm
F-1
EX-10.8
u23l40 j25c
7 Jan 19
Registration statement (foreign)
5:11pm
F-1
EX-10.7
y915isr1
7 Jan 19
Registration statement (foreign)
5:11pm